Krystal Biotech buy Citigroup Inc.
Start price
27.02.24
/
50%
€152.00
Target price
27.02.25
€179.60
Performance (%)
14.14%
End price
28.02.25
€173.50
Summary
This prediction ended on 28.02.25 with a price of €173.50. The prediction had a final performance of 14.14%. Citigroup_Inc_ has a follow-up prediction for Krystal Biotech where he still thinks Krystal Biotech is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Krystal Biotech | -2.169% | -2.169% | 52.099% |
| iShares Core DAX® | 2.554% | 0.562% | 14.142% |
| iShares Nasdaq 100 | 2.742% | -0.599% | 30.370% |
| iShares Nikkei 225® | 6.584% | 4.336% | 49.372% |
| iShares S&P 500 | 1.930% | -0.507% | 24.257% |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
In the thread Trading Krystal Biotech
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Citigroup_Inc_ for Krystal Biotech
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€233.70
12.01.26
12.01.26
€288.19
12.01.27
12.01.27
-5.43%
10.04.26
10.04.26
